CompletedPhase 3NCT01717742

Intrapleural DNase and Tissue Plasminogen Activator in Pediatric Empyema (DTPA Trial)

Studying Pleural empyema

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The Hospital for Sick Children
Principal Investigator
Eyal Cohen, MD, MSc
The Hospital for Sick Children
Intervention
TPA (Tissue Plasminogen Activator)(drug)
Enrollment
97 target
Eligibility
18 years · All sexes
Timeline
2012 – 2017

Study locations (6)

Collaborators

Canadian Institutes of Health Research (CIHR) · Children's Hospital of Eastern Ontario · St. Justine's Hospital · Unity Health Toronto · The Physicians' Services Incorporated Foundation · McMaster Children's Hospital · British Columbia Children's Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01717742 on ClinicalTrials.gov

Other trials for Pleural empyema

Additional recruiting or active studies for the same condition.

See all trials for Pleural empyema →

← Back to all trials